← Back to Search

Education at the first follow up for Chronic Multifocal Osteomyelitis

N/A

Recruiting

Research Sponsored by Seattle Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of CRMO

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-9 months

Awards & highlights

Study Summary

This trial aims to understand how often children with CRMO at Seattle Children's Hospital do not take their medication as prescribed, and what factors might make it difficult for them to stick to their treatment plan.

Who is the study for?

This trial is for pediatric patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) being treated at Seattle Children's Hospital. The study focuses on those who have not yet received educational materials about managing their medication.Check my eligibility

What is being tested?

The study tests if giving educational materials to help manage medications improves how well kids with CRMO stick to their treatment plans. Patients are randomly placed into two groups; one gets the info after their first visit, and the other after their second visit.See study design

What are the potential side effects?

Since this trial involves education on medication management rather than a medical intervention, there are no direct side effects from drugs or treatments. However, stress or anxiety related to understanding and managing the condition could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with CRMO.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Medication possession ratio (MPR)

Secondary outcome measures

Barriers to adherence

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Education at the first follow upExperimental Treatment1 Intervention

video and AVS education will be provided at the first follow up visit

Group II: Education at baselineActive Control1 Intervention

video and ambulatory visit summary (AVS) education will be provided at baseline visit

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER

1,741 Previous Clinical Trials

1,847,642 Total Patients Enrolled

Seattle Children's HospitalLead Sponsor

304 Previous Clinical Trials

5,217,182 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"Indeed, as indicated on clinicaltrials.gov, this ongoing research study is actively seeking individuals to participate. The trial was initially posted on February 20th, 2024 and recently updated on January 28th, 2024."

Answered by AI

What is the current number of participants enrolled in this research study?

"Indeed, as indicated by the information on clinicaltrials.gov, this ongoing study is currently enrolling participants. The trial was initially posted for recruitment purposes on February 20th, 2024 and subsequently updated lastly on January 28th, 2024. A total of 118 patients will be admitted to a single designated location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)

Yongdong (Dan) Zhao 2024. "Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06232603.

All > Paid Studies Seattle